MOTS EN ANGLAIS EN RAPPORT AVEC «ANTITHROMBIN»
antithrombin
deficiency
pregnancy
normal
range
heparin
symptoms
drugs
treatment
antithrombin
small
protein
molecule
that
inactivates
several
enzymes
coagulation
system
glycoprotein
produced
also
referred
older
literature
genetically
acquired
trait
although
there
other
diseases
including
some
test
tests
describes
testing
used
when
ordered
what
results
might
mean
congenital
national
library
medicine
causes
naturally
blocks
clots
from
forming
inherited
disease
depth
guide
patients
healthcare
providers
stephan
moll
medscape
10 LIVRES EN ANGLAIS EN RAPPORT AVEC «ANTITHROMBIN»
Découvrez l'usage de
antithrombin dans la sélection bibliographique suivante. Des livres en rapport avec
antithrombin et de courts extraits de ceux-ci pour replacer dans son contexte son utilisation littéraire.
1
Principles of Pharmacology: The Pathophysiologic Basis of ...
Mechanism of Action of Heparin Heparin's mechanism of action depends on the
presence of a specific plasma protease inhibitor, antithrombin III (Fig. 22-9).
Antithrombin III is actually a misnomer because, in addition to inactivating
thrombin, ...
David E. Golan, Armen H. Tashjian, Ehrin J. Armstrong, 2011
2
Blood: Principles and Practice of Hematology
Acquired Antithrombin, Protein C, and Protein S Deficiency States Protein C
deficiency Warfarin Severe meningococcemia Protein S deficiency Warfarin
Pregnancy Nephrotic syndrome Estrogen Severe varicella infections
Antithrombin ...
Robert I. Handin, Samuel E. Lux, Thomas P. Stossel, 2003
3
Wintrobe's Clinical Hematology
Antithrombin-HI is a member of the serpin proteinase inhibitory family and
circulates in blood as a single-chain glycoprotein (285) (Table 20.4). Its t,/2 is
approximately 61 to 72 hours (1318,1319). Other names for antithrombin-III
include ...
4
Thrombosis Reduction by Mass Transport-enhanced Recombinant ...
Murano G, Williams L, Milier-Andersson M, Aronson DL, and King C. Some
properties of antithrombin-IIl and its concentration in human plasma. Thromb Res
18:259-262, 1980. 147. Nelsestuen GL. Interactions of vitamin K-dependent
proteins ...
5
Laboratory Techniques in Thrombosis - A Manual
Abildgaard U. Antithrombin and related inhibitors of coagulation. In: Poller L, ed.
Recent advances in blood coagulation. Edinburgh: Churchill Livingstone, 1981;
151. 2. Rosenberg RD, Bauer KA. The heparin-antithrombin system: a natural ...
J. Jespersen, R.M. Bertina, F. Haverkate, 2000
6
Thromboembolic Complications During Infancy and Childhood
Thromb Haemost 1987:58:1094-5. 234. Lane DA, Olds RJ, Boisclair M, et al.
Antithrombin III mutation database: first update. Thromb Haemost 1993:70:361-9.
235. Bock SC, Harris JF, Balazs I, Trent JM. Assignment of the human
antithrombin ...
Maureen Andrew, Paul T. Monagle, LuAnn Brooker, 2000
7
Hemostasis and Thrombosis: Basic Principles and Clinical ...
by antithrombin IIl-independent inhibitors. J Clin lnvest 1990;86: 385-391. 79.
Weitz J, l.eslie B, Hudoba M. Thrombin binds to soluble fibrin degradation
products where it is protected from inhibition by heparin-antithrom- bin by
susceptible to ...
8
Yearbook of Intensive Care and Emergency Medicine 2010
Kowal-Vern and colleagues reported the first evidence for the safety of
antithrombin in burned patients in a case report of a 40 year old man with a 68%
TBSA burn without identified inhalation injury [42]. The patient received nine
infusions of ...
9
36th Hemophilia Symposium Hamburg 2005: Epidemiology; ...
We believe that the base exchange in the antithrombin gene of the patient
represents a novel mutation.The existence of this mutation in the patient's baby
supports the assumption of the antithrombin deficiency as a hereditary disorder.
G. Auerswald, Inge Scharrer, A. Kurth, 2007
10
Protein Misfolding, Aggregation and Conformational Diseases: ...
15.2.4. Latent Antithrombin, Propagation, and Prions Although it was early
proposed that the serpins in general had the potential to undergo a
transformation to the inert (6-stranded A-sheet) latent form, the results with the
candidate serpin, ...
Vladimir N. Uversky, Anthony Fink, 2007
10 ACTUALITÉS CONTENANT LE TERME «ANTITHROMBIN»
Découvrez de quoi on parle dans les médias nationaux et internationaux et comment le terme
antithrombin est employé dans le contexte des actualités suivantes.
Alnylam's hemophilia candidate reduces levels of anticoagulant in …
... Phase I trial results, which indicated that the candidate can knock down levels of the anticoagulant known as antithrombin (AT) by up to 86%. «FierceDrugDelivery, juin 15»
Too 100 Agencies 2015: Beacon Healthcare Communications
One of his favorite examples is work the agency did for ATryn, which prevents thromboembolic events in hereditary antithrombin-deficient ... «Medical Marketing and Media, juin 15»
Research and Markets: Future Horizons and Growth Strategies in …
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, ... «Digital Journal, juin 15»
Antithrombin III Deficiency Testing Market – Global Industry Analysis …
Antithrombin III is a non-vitamin, K-dependent protease that naturally blocks abnormal blood clot formation in the bloodstream. Deficiency of ... «Medgadget.com, juin 15»
Dr. Garrett Lam Studies Possible Treatment For Early Onset …
Short-term use of antithrombin has been previously shown in two studies to prolong gestation. This is the first study looking at whether ... «The Chattanoogan, juin 15»
FDA Approves New Antiplatelet Drug Used During Cardiac Procedure
More than 700,000 such procedures each year in the United States require antithrombin and antiplatelet therapy. As with other FDA-approved ... «Pharmacy Practice News, juin 15»
Alnylam Reports New Positive Clinical Data for ALN-AT3, a …
Antithrombin (AT, also known as “antithrombin III” and “SERPINC1”) is a ... antithrombin deficiency, amongst others), certain mutations result in ... «MarketWatch, juin 15»
The Medicines Co. Antiplatelet Drug Kengreal Wins FDA Nod …
Taking into account the number of PCI procedures requiring antithrombin and antiplatelet therapy, we believe Kengreal holds significant ... «Nasdaq, juin 15»
Heparin Market Is Expected to Reach USD 3.14 Billion in Europe by …
Biological activity of heparin depends on antithrombin III, which bind and deactivate serum clotting factor leading to anti-coagulation effect. «Digital Journal, juin 15»
Critical Care Market to 2019 Analysis & Forecast- Growth from …
... expanded indication for Antithrombin (AT) III and factor concentrates, and rising demand for albumin from countries in the Asia-Pacific region. «Medgadget.com, juin 15»
